4/A//SEC Filing
COUCHMAN JONATHAN 4/A
Accession 0000921895-20-000958
CIK 0000727510other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 6:34 PM ET
Size
19.0 KB
Accession
0000921895-20-000958
Insider Transaction Report
Form 4/AAmended
COUCHMAN JONATHAN
10% OwnerOther
Transactions
- Purchase
Common Stock, $0.01 par value
2020-03-23$0.14/sh+2,678$375→ 2,928 total(indirect: By Myrexis, Inc.) - Purchase
Common Stock, $0.01 par value
2020-03-26$0.14/sh+160,785$22,510→ 633,264 total(indirect: By Myrexis, Inc.) - Purchase
Common Stock, $0.01 par value
2020-03-13$0.14/sh+19,709$2,661→ 1,594,232 total(indirect: By Xstelos Corp.) - Purchase
Common Stock, $0.01 par value
2020-03-25$0.14/sh+469,551$65,737→ 472,479 total(indirect: By Myrexis, Inc.)
Holdings
- 4,717,666
Common Stock, $0.01 par value
- 400,000(indirect: By Couchman Family Fund)
Common Stock, $0.01 par value
Couchman Family Fund
Other
Transactions
- Purchase
Common Stock, $0.01 par value
2020-03-23$0.14/sh+2,678$375→ 2,928 total(indirect: By Myrexis, Inc.) - Purchase
Common Stock, $0.01 par value
2020-03-25$0.14/sh+469,551$65,737→ 472,479 total(indirect: By Myrexis, Inc.) - Purchase
Common Stock, $0.01 par value
2020-03-26$0.14/sh+160,785$22,510→ 633,264 total(indirect: By Myrexis, Inc.) - Purchase
Common Stock, $0.01 par value
2020-03-13$0.14/sh+19,709$2,661→ 1,594,232 total(indirect: By Xstelos Corp.)
Holdings
- 4,717,666
Common Stock, $0.01 par value
- 400,000(indirect: By Couchman Family Fund)
Common Stock, $0.01 par value
Xstelos Corp.
Other
Transactions
- Purchase
Common Stock, $0.01 par value
2020-03-23$0.14/sh+2,678$375→ 2,928 total(indirect: By Myrexis, Inc.) - Purchase
Common Stock, $0.01 par value
2020-03-13$0.14/sh+19,709$2,661→ 1,594,232 total(indirect: By Xstelos Corp.) - Purchase
Common Stock, $0.01 par value
2020-03-25$0.14/sh+469,551$65,737→ 472,479 total(indirect: By Myrexis, Inc.) - Purchase
Common Stock, $0.01 par value
2020-03-26$0.14/sh+160,785$22,510→ 633,264 total(indirect: By Myrexis, Inc.)
Holdings
- 400,000(indirect: By Couchman Family Fund)
Common Stock, $0.01 par value
- 4,717,666
Common Stock, $0.01 par value
Myrexis, Inc.
10% Owner
Transactions
- Purchase
Common Stock, $0.01 par value
2020-03-25$0.14/sh+469,551$65,737→ 472,479 total(indirect: By Myrexis, Inc.) - Purchase
Common Stock, $0.01 par value
2020-03-13$0.14/sh+19,709$2,661→ 1,594,232 total(indirect: By Xstelos Corp.) - Purchase
Common Stock, $0.01 par value
2020-03-23$0.14/sh+2,678$375→ 2,928 total(indirect: By Myrexis, Inc.) - Purchase
Common Stock, $0.01 par value
2020-03-26$0.14/sh+160,785$22,510→ 633,264 total(indirect: By Myrexis, Inc.)
Holdings
- 4,717,666
Common Stock, $0.01 par value
- 400,000(indirect: By Couchman Family Fund)
Common Stock, $0.01 par value
Footnotes (4)
- [F1]This Form 4 is filed jointly by Jonathan Couchman ("Mr. Couchman"), Couchman Family Fund (the "Foundation"), Xstelos Corp. ("Xstelos") and Myrexis, Inc. ("Myrexis" and, together with Mr. Couchman, the Foundation and Xstelos, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons expressly disclaims beneficial ownership of the Shares reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such Shares for purposes of Section 16 or for any other purpose.
- [F2]Represents Shares owned directly by Xstelos. Mr. Couchman is the controlling shareholder and Chief Executive Officer of Xstelos. By virtue of these relationships, Mr. Couchman may be deemed to beneficially own the Shares owned directly by Xstelos. Mr. Couchman expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
- [F3]Represents Shares owned directly by the Foundation. Mr. Couchman is the sole trustee of the Foundation. By virtue of this relationship, Mr. Couchman may be deemed to beneficially own the Shares owned directly by the Foundation, however he has no pecuniary interest in such Shares.
- [F4]Represents Shares owned directly by Myrexis. Mr. Couchman is Chief Executive Officer of Myrexis. By virtue of this relationship, Mr. Couchman may be deemed to beneficially own the Shares owned directly by Myrexis. Mr. Couchman expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
Documents
Issuer
ENZON PHARMACEUTICALS, INC.
CIK 0000727510
Entity typeother
Related Parties
1- filerCIK 0001265094
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 6:34 PM ET
- Size
- 19.0 KB